CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The ReLiV project is advancing a handheld diagnostic device called DiaNose, which uses an array of sensors to analyze volatile organic compounds in breath. This technology aims to provide non-invasive, accurate diagnostics for various diseases, starting with Non-Alcoholic Fatty Liver Disease.
The analysis of volatile organic compounds (VOCs) in exhaled breath with nano sensors has great potential to transform healthcare, with accurate, inexpensive, real-time diagnostics.
However, attempts to implement this strategy have failed to reach clinical deployment.
Firstly, many efforts try to identify the complex mixture of VOCs associated with disease, which is a long and expensive process.
Secondly, commercially available sensors require high operating temperatures and have low sensitivity…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
